{"component":{"type":17,"accent_color":10660273,"components":[{"type":10,"content":"-# WikiRNG · Roll of 10/30/2026 · by [Dess\\_Nots](https://wikirng.com/u/Dess_Nots)"},{"type":10,"content":"## [Lepodisiran](https://wikirng.com/roll/P8VQE0)\n*Small interfering RNA*"},{"type":10,"content":">>> Lepodisiran (LY3819469) is a small interfering RNA that was developed to reduce lipoprotein(a) in people at risk of cardiovascular disease. It was developed by Eli Lilly and Company."},{"type":14,"divider":true,"spacing":1},{"type":10,"content":"### ⬜ Basic · 19,571 SP\n-# Bottom 18%"},{"type":10,"content":"*(LY3819469) is small*"},{"type":14,"divider":true,"spacing":1},{"type":10,"content":"🟩 🦓 **Zebra** · Notable · +6,938 SP\n-# The title's letters alternate vowel and consonant (7+ letters).\n🟩 🧬 **PubMed** · Notable · +3,090 SP\n-# Links to PubMed.\n🟩 🔓 **Free to Read** · Notable · +1,731 SP\n-# Cites a source that is free to read.\n🟩 💎 **Prime ID** · Notable · +1,675 SP\n-# Page ID is a prime number.\n🟩 🔀 **Anagram** · Notable · +1,031 SP\n-# Another article's title uses the same letters in another order (4+ letters).\n⬜ 1️⃣ **One Word** · Basic · +813 SP\n-# Title is one word.\n-# +13 more badges"},{"type":14,"divider":true,"spacing":1},{"type":1,"components":[{"type":2,"style":5,"label":"View roll","url":"https://wikirng.com/roll/P8VQE0"},{"type":2,"style":5,"label":"Read on Wikipedia","url":"https://en.wikipedia.org/wiki/Lepodisiran"}]},{"type":10,"content":"-# Article text from Wikipedia, CC BY-SA 4.0"}]}}